CAJ | 학술논문

目的：评价胺碘酮联合步长稳心颗粒治疗阵发性快速房颤的疗效。方法将80例阵发性快速房颤患者随机分为治疗组和对照组，两组均予以吸氧、心电监护、胺碘酮治疗，治疗组加服步长稳心颗粒，共观察6个月。结果观察6个月后，治疗组在有效改善症状、复律时间、及胺碘酮用量方面明显优于对照组，差异有统计学意义（P<0.01）。结论胺碘酮与步长稳心颗粒合用治疗阵发性房颤，能有效改善症状，提高治疗效果且可减少胺碘酮用量，缩短复律时间，有一定的临床应用价值。
목적：평개알전동연합보장은심과립치료진발성쾌속방전적료효。방법장80례진발성쾌속방전환자수궤분위치료조화대조조，량조균여이흡양、심전감호、알전동치료，치료조가복보장은심과립，공관찰6개월。결과관찰6개월후，치료조재유효개선증상、복률시간、급알전동용량방면명현우우대조조，차이유통계학의의（P<0.01）。결론알전동여보장은심과립합용치료진발성방전，능유효개선증상，제고치료효과차가감소알전동용량，축단복률시간，유일정적림상응용개치。
Objective Evaluation of amiodarone the joint step Wenxinkeli rapid atrial fibrillation in patients with paroxysmal efficacy. Methods 80 patients with paroxysmal rapid atrial fibrillation were randomly divided into a treatment group and a control group, and both groups are oxygen, ECG, amiodarone,The treatment group took Buchangwenxin particles were observed 6 months. Results Observed after 6 months, the treatment group was effective in improving symptoms, time of cardioversion and amiodarone dosage was significantly better than the control group, the difference was statistically significant (P <0.01). Conclusion the particle combination therapy of paroxysmal atrial fibrillation, amiodarone and Buchangwenxin improve symptoms, improve treatment and reduce amiodarone dosage and shorten the time of cardioversion clinical application value.